The treatment success rate for patients treated for multidrug-resistant tuberculosis in Germany is on a declining trend. The data shows a decrease from 31% in 2024 to 27% by 2028. This trend indicates a consistent annual drop, with each year witnessing a 1 percentage point decline. This downward trajectory raises concerns compared to 2023's actual figures, which were notably higher, suggesting potential challenges in treatment efficacy or patient compliance.

Future trends to watch for include:

Emerging advancements in tuberculosis treatment and medications.
Government and healthcare initiatives aimed at improving patient outcomes.
Potential impacts of public health policy changes on combating drug-resistant strains.